Geron (GERN) Equity Average (2011 - 2026)
Geron's (GERN) quarterly Equity Average came in at $227.5 million in Q1 2026, down 17.06% year-on-year from $274.3 million in Q1 2025, and down 4.13% quarter-over-quarter from $237.3 million in Q4 2025.
Geron (GERN) Equity Average (2011 - 2026) Analysis & Trends
Geron has disclosed Equity Average across 16 years of filings, most recently posting $227.5 million for Q1 2026.
- Equity Average for Q1 2026 came in at $227.5 million, down 17.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $227.5 million (down 17.06% YoY), and the FY2025 annual result was $253.1 million, down 4.18% from the prior year.
- Equity Average came in at $227.5 million for Q1 2026 at Geron, down from $237.3 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $325.8 million in Q2 2024 to a low of $94.1 million in Q4 2022.
- The 5-year median for Equity Average is $263.9 million (2025), against an average of $235.0 million.
- Across the five-year window, Equity Average tumbled 45.67% in 2022 and jumped 186.21% in 2023, its largest moves.
- Geron's Equity Average stood at $94.1 million in 2022, then surged by 186.21% to $269.3 million in 2023, then advanced by 6.32% to $286.3 million in 2024, then declined by 17.12% to $237.3 million in 2025, then fell by 4.13% to $227.5 million in 2026.
- The last three Equity Average figures came in at $227.5 million (Q1 2026), $237.3 million (Q4 2025), and $254.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 516.41 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 227.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.49 Mn |
| Dec 31, 2025 | 237.29 Mn |
| Sep 30, 2025 | 254.12 Mn |
| Jun 30, 2025 | 263.88 Mn |
| Mar 31, 2025 | 274.28 Mn |
| Dec 31, 2024 | 286.30 Mn |
| Sep 30, 2024 | 299.49 Mn |
| Jun 30, 2024 | 325.78 Mn |
| Mar 31, 2024 | 296.41 Mn |
| Dec 31, 2023 | 269.28 Mn |
| Sep 30, 2023 | 294.52 Mn |
| Jun 30, 2023 | 312.24 Mn |
| Mar 31, 2023 | 203.03 Mn |
| Dec 31, 2022 | 94.09 Mn |
| Sep 30, 2022 | 125.11 Mn |
| Jun 30, 2022 | 119.77 Mn |
| Mar 31, 2022 | 111.95 Mn |
| Dec 31, 2021 | 138.98 Mn |
| Sep 30, 2021 | 163.88 Mn |
| Jun 30, 2021 | 188.68 Mn |